Trial Profile

Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 29 Apr 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

07 Mar 2025 Number of treatment arms are increased from 1 to 2 by the addition of Experimental: Part 2: INV-102 0.7% in Center-involved Diabetic Macular Edema (CIDME) arm. Inclusion criteria is also expanded to include both kinds of subjects having NCIDME (in Part 1) or CIDME (in Part 2).
03 Dec 2024 Planned End Date changed from 1 Mar 2025 to 1 Aug 2025.
03 Dec 2024 Planned primary completion date changed from 1 Mar 2025 to 1 Aug 2025.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com